Laura Sararols

ORCID: 0009-0009-7533-4076
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Intraocular Surgery and Lenses
  • Retinal and Macular Surgery
  • Ocular Diseases and Behçet’s Syndrome
  • Glaucoma and retinal disorders
  • Retinal Development and Disorders
  • Ocular Oncology and Treatments
  • Ocular Infections and Treatments
  • Retinopathy of Prematurity Studies
  • Corneal surgery and disorders
  • Ophthalmology and Visual Impairment Studies
  • Vascular Malformations Diagnosis and Treatment
  • Nitric Oxide and Endothelin Effects
  • Dermatological and Skeletal Disorders
  • Medical History and Innovations
  • Ocular Surface and Contact Lens
  • Dental Anxiety and Anesthesia Techniques
  • Glioma Diagnosis and Treatment
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Acute Ischemic Stroke Management
  • CNS Lymphoma Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • Vascular Tumors and Angiosarcomas

Hospital General de Granollers
2018-2025

Vision Australia
2024

ACT Government
2024

Centre Hospitalier de Saint-Brieuc
2024

CHU Dijon Bourgogne
2024

Canberra Hospital
2024

Centre for Eye Research Australia
2024

Hospital General de Catalunya
2016-2022

Universitat Autònoma de Barcelona
1997-2007

Instituto de Microcirugía Ocular
2007

To assess the safety and efficacy of different doses RTH258 applied as single intravitreal administration compared with ranibizumab 0.5 mg in patients neovascular age-related macular degeneration (AMD).Six-month, phase 1/2, prospective, multicenter, double-masked, randomized, ascending single-dose, active-controlled, parallel-group study.A total 194 treatment-naive patients, aged ≥50 years, primary subfoveal choroidal neovascularization secondary to AMD.Patients received a injection (n =...

10.1016/j.ophtha.2015.12.030 article EN cc-by-nc-nd Ophthalmology 2016-02-20

To evaluate the efficacy, effect profile, and safety of dexamethasone implant on diabetic macular edema (DME) in a real-life setting, further comparing results by DME duration, previous treatment status, control.A multicenter, retrospective cohort 340 eyes 287 patients from 25 clinical sites 8 countries.Data were analyzed 2 perspectives: per injection, which all measurements grouped baseline was defined as day thus pharmacodynamics single injections could be assessed; injection series, or...

10.1016/j.ophtha.2019.10.005 article EN cc-by-nc-nd Ophthalmology 2019-10-10

Aim To explore associations between artificial intelligence (AI)-based fluid compartment quantifications and 12 months visual outcomes in OCT images from a real-world, multicentre, national cohort of naïve neovascular age-related macular degeneration (nAMD) treated eyes. Methods Demographics, acuity (VA), drug number injections data were collected using validated web-based tool. Fluid including intraretinal (IRF), subretinal (SRF) pigment epithelial detachment (PED) the fovea (1 mm),...

10.1136/bjo-2022-322297 article EN British Journal of Ophthalmology 2023-01-10

Geographic atrophy (GA) secondary to age-related macular degeneration is a common cause of blindness worldwide. Given the recent approval first therapy for GA, pegcetacoplan, we critically appraise methodological aspects phase 3 clinical trials published so far in this disease relation their design, analysis and interpretation. We reviewed some key attributes all GA available main public registry as 20 May 2023. The topics discussed included types endpoints, eligibility criteria, p-value...

10.3390/biomedicines11061548 article EN cc-by Biomedicines 2023-05-26

Aim To evaluate the impact of fluid volume fluctuations quantified with artificial intelligence in optical coherence tomography scans during maintenance phase and visual outcomes at 12 24 months a real-world, multicentre, national cohort treatment-naïve neovascular age-related macular degeneration (nAMD) eyes. Methods Demographics, acuity (VA) number injections were collected using Fight Retinal Blindness tool. Intraretinal (IRF), subretinal (SRF), pigment epithelial detachment (PED), total...

10.1136/bjo-2024-325615 article EN British Journal of Ophthalmology 2025-01-23

Purpose: To determine if vitreoretinal surgery is successful in closing traumatic macular holes and subsequently improving visual acuity. Blunt trauma may result a hole when it causes separation of the vitreous from retina, contusion necrosis, or subfoveal hemorrhage. Like idiopathic holes, are surrounded by ring subretinal fluid severely diminished Methods: Fourteen eyes with full-thickness posttraumatic were treated. The patients' ages ranged 15 years to 36 (mean, 22 years). Preoperative...

10.1097/00006982-199709000-00003 article EN Retina 1997-09-01

Purpose: To compare the visual disturbances experienced by patients receiving 1 of 3 extended depth-of-focus (EDOF) intraocular lenses (IOLs) or a monofocal IOL as control. Setting: OMIQ-Recerca Center. Spain. Design: Prospective comparative randomized double-blind study. Methods: 22 were included per group. The IOLs evaluated AcrySof IQ Vivity (Vivity group), AT LARA 829MO (AT Lara TECNIS Symfony ZXR00 (Symfony group) and SN60WF (Monofocal group). variables analyzed light distortion index...

10.1097/j.jcrs.0000000000000988 article EN Journal of Cataract & Refractive Surgery 2022-06-21

OBJECTIVE—To evaluate the vitreous levels of somatostatin-like immunoreactivity (SLI) in patients with proliferative diabetic retinopathy (PDR). RESEARCH DESIGN AND METHODS—A total 14 PDR, whom a vitrectomy was performed, were included study. Sixteen nondiabetic patients, other conditions requiring vitrectomy, served as control group. Both venous blood and samples collected at time vitreoretinal surgery. Patients intravitreous hemoglobin detectable excluded. In addition, correction for...

10.2337/diacare.25.12.2282 article EN Diabetes Care 2002-12-01

Eyes with posterior choroidal melanomas more than 9 mm in thickness frequently are enucleated because of the potential complications radiotherapy. The aim this study was to evaluate safety and efficacy internal resection these tumors.Twenty-five consecutive patients high a diameter less 15 greater were treated. If retina not invaded by tumor, vitrectomy performed, followed hyaloid dissection, 120 degrees anterior retinotomy, endophotocoagulation 2 past tumor margin, melanoma removal probe,...

10.1097/00006982-200110000-00005 article EN Retina 2001-10-01

To assess the relationship between risk for acute endophthalmitis after cataract extraction and whether certain factors, such as surgeon qualification, numerical order, duration of surgery, operating theater, type anesthesia (topical or retrobulbar), could be modified to decrease risk.Single-center academic practice.Two epidemiological studies were performed: a case-control study retrospective cohort study. The surgical records all patients with clinically diagnosed within 30 days surgery...

10.1016/j.jcrs.2007.02.030 article EN Journal of Cataract & Refractive Surgery 2007-05-25

To study the visual outcomes of neovascular AMD (nAMD) treated with anti-vascular endothelial growth factor (VEGF) drugs at national level.Multicenter database nAMD eyes anti-VEGF intravitreal injections (ranibizumab, aflibercept, bevacizumab) in fixed bimonthly (FB) or treat-and-extend (TAE) regimens. Demographics, acuity (VA) logarithm minimum angle resolution (logMAR) ETDRS letters baseline and subsequent visits, number visits data were collected using a validated web-based tool (Fight...

10.1111/ceo.14054 article EN Clinical and Experimental Ophthalmology 2022-02-02

Brolucizumab, a new generation anti-VEGF, has demonstrated efficacy and safety in AMD the pivotal HAWK HARRIER trials. Post-marketing, previously undetected adverse events related to intraocular inflammation have been reported. An independent post hoc review of trials puts rate IOI at 4.6%. The aim this paper is propose set recommendations for implementing management brolucizumab clinical practice. made by authors are based on their experience, critical (i) trials, post-hoc analysis Safety...

10.1016/j.oftale.2022.05.006 article FR cc-by Archivos de la Sociedad Española de Oftalmología (English Edition) 2022-07-23

The purpose was to compare two flexible regimens of intravitreal aflibercept (IVT-AFL) with fixed dosing every 8 weeks, beyond the first year treatment, in patients diabetic macular edema (DME). VIOLET a 100-week, randomized, Phase IIIb, non-inferiority study center-involving DME previously treated IVT-AFL for ≥ 1 according European label.Patients received an initial dose at baseline and were randomly assigned (1:1:1) treat-and-extend (T&E), pro re nata (PRN), or regimens. primary endpoint...

10.1007/s12325-022-02119-z article EN cc-by-nc Advances in Therapy 2022-04-12
Hemal Mehta Pierre‐Henry Gabrielle Yohei Hashimoto Getiye Dejenu Kibret Jennifer Arnold and 95 more Tremeur Guillaumie Wajiha Jurdi Kheir Gerhard Kok Stela Vujosevic Louise O’Toole Els Mangelschots Nandor Jaross Lala Ćeklić Vincent Daïen Francesco Viola David Squirrell Francisco Javier Lavid Catherine Creuzot‐Garcher Daniel Barthelmes Mark C. Gillies A. Miri Adrian T. Fung Alejandro Higueras Alessandro Invernizzi Alex Hamilton Amy Cohn Ann Vanderschueren Benjamin Wolff Bougamha Walid Charles Hennings Charmaine Chung Chris Hornsby Cinthia Rethati Daniel Barthelmes Daniel Velázquez-Villoria David Squirrell Derek Chan Edwin K. P. Chong Els Mangelschots Ester Carreño Florian Baudin Francesco Viola Francisco Javier Lavid Gerhard Kok G. Furness Guillaume Michel Heather G. Mack Helen Steiner Hemal H. Mehta Ian Reddie J. C. ACTON Jane M. Wells Jennifer Arnold Joel Suárez Jolly Gilhotra Justin O’Day Lala Ćeklić Laura Sararols Les Manning Li Ping Chow Louise O’Toole Luis Cordovés M.P. Arrazola María Eugenia Tena Sempere María Pilar Navarro Mark C. Gillies M. Morgan Marta Rodriguez Núñez Michel Weber Miguel Castilla Marti Miguel de la Fuente M. Asencio Durán Nandor Jaross Pablo Catalán Muñoz Pablo Carnota Patrick Lockie Paul Beaumont Peter Hinchcliffe Pierre‐Henry Gabrielle Pilar Calvo Rachel Barnes R. Chalasani Richard Barry Robert Chong Roberto Gallego‐Pinazo Ross Ferrier Samantha Fraser‐Bell Sandrine Allieu Sanjeev Wickremasinghe Sarah Tick Sarah Welch Saturnino Manuel Gismero Moreno S. Nothling S. Aparicio-Sanchis Stela Vujosevic Stephanie Young S. J. Wan Terence Tan Tremeur Guillaumie Vincent Daïen

To compare 1-year outcomes of eyes with diabetic macular edema (DME) treated in routine clinical practice based on the proportion visits where intravitreal VEGF inhibitor injections were delivered.

10.1016/j.oret.2024.04.008 article EN cc-by Ophthalmology Retina 2024-04-16
Eloi Debourdeau H. Beylerian Vuong Nguyen Daniel Barthelmes Mark C. Gillies and 95 more Pierre‐Henry Gabrielle Stela Vujosevic Louise O’Toole Martin Puzo Catherine Creuzot‐Garcher Benjamin Wolff Vincent Daïen Amy Cohn Bacchus Marsh Nandor Jaross Richard Barry I. W. McLean Tremeur Guillaumie A. Miri Pierre‐Henry Gabrielle Sarah Tick Andy P. Field Sanj Wickremasinghe C. Dayajeewa John A. Wells Adrian Dunlop Stephanie Young G. Mimoun Robyn H. Guymer Pablo Carnota Roberto Gallego‐Pinazo Alfredo García‐Layana Manuel Sáenz de Viteri R. Ferrier Lu‐Ping Chow H Steiner Ali Amini Jian Chen Nilanjan Saha P. Windle Mark C. Gillies Anna Hunt P. Beaumont Z. Louw Alan Luckie Stewart Lake Dania Qatarneh Laura Sararols J. Suárez Paula Berdoukas Francesco Viola R. Montejano-Milner Carolina Arruabarrena FJ ASCASO Ana Boned Murillo M Díaz Guillermo Pérez Rivasés S. Alforja Castiella Ricardo P. Casaroli‐Marano Marc Figueras‐Roca Javier Zarranz‐Ventura Saturnino Gismero-Moreno Antonio Escobar JMoreno Gutiérrez J. Escobar Francisco Javier Lavid Pablo Catalán Muñoz M. Tena Sempere Federico Ricci L. Broc Iturralde S. Gómez Sánchez Gonzaga Garay‐Aramburu N. Munoz Sanz Pilar Calvo Jorge Sánchez Elena Alonso María García Zamora E. Ciancas J.J. González‐López Daniel Lorenzo M. Acebes S. Aparicio-Sanchis Ana Fernández-Hortelano A. Piñero Sánchez L. García García E. Salinas Martínez A. Campo Gesto M. Rodriguez Núñez L. Manning Alessandro Invernizzi Laurent Castelnovo Guillaume Michel Benjamin Wolff M. Perks Jennifer Arnold H. Cass Louise O’Toole Kea‐Tiong Tang C. Chung Vincent Daïen

ou non, émanant des établissements d'enseignement et de recherche français étrangers, laboratoires publics privés.

10.1007/s40123-024-00983-2 article FR cc-by-nc Ophthalmology and Therapy 2024-07-08

Abstract Aims Several reports have implicated nitric oxide (NO) in the angiogenic process. The assessment of NO stable end products, nitrite and nitrate (NOx), is commonly used as a measure production biological fluids. aims study were to investigate NOx concentrations vitreous fluid patients with proliferative diabetic retinopathy (PDR) evaluate relationship between vascular endothelial growth factor (VEGF). Patients methods Serum samples obtained simultaneously at time vitreoretinal...

10.1046/j.1464-5491.2002.00768.x article EN Diabetic Medicine 2002-07-30

This study aimed to characterize the visual performance in patients with bilateral cataracts and a unilateral epiretinal membrane (ERM) undergoing cataract surgery non-diffractive extended depth of focus (EDoF) intraocular lens (IOL) placement both eyes phacovitrectomy eye ERM.

10.3390/biomedicines12112443 article EN cc-by Biomedicines 2024-10-24

The aim of the study was to evaluate vitreous levels free insulin-like growth factor 1 (IGF-1) in patients with proliferative diabetic retinopathy (PDR). For this, a total 36 PDR (group A) and 28 non-diabetic B) whom vitrectomy performed were compared. Both groups matched by age, sex serum-free IGF-1. In subgroup (n = 21) 13), serum IGF-1, IGF-binding protein (IGFBP-1) IGFBP-3 also determined. Serum IGFBP-1 measured immunological methods. Vitreal proteins assessed turbidimetric method...

10.1042/cs20020278 article EN Clinical Science 2003-03-01
Coming Soon ...